Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Merck & Co. claims carbapenems active against methicillin-resistant staphylococci

Jan. 19, 1998

Preclinical evaluation of leishmaniasis Rx reported

Jan. 19, 1998

Artelinic acid: an attractive candidate for development as an antimalarial agent

Jan. 19, 1998

New antimalarial agent submitted to extensive clinical testing

Jan. 19, 1998

U. of Mass. scientists design anti-EBV antisense oligonucleotides

Jan. 16, 1998

Lilly describes new glycopeptides active against VRE

Jan. 15, 1998

Genzyme Transgenics breakthrough could lead to potential malaria vaccine

Jan. 14, 1998

Carbapenems with enhanced antipseudomonal activity and stability

Jan. 14, 1998

DuPont Merck, Signal collaborate on HCV and HIV research

Jan. 14, 1998

Preclinical and preliminary clinical results reported for CS-834

Jan. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...